Skip navigation

Learn how ddPCR is enabling rare sequence quantification and CRISPR validation

10:30 - 13:30

Hardwick Room, Babraham Research Campus, Cambridge, CB22 3AT
03 June 2015

Continuing One Nucleus work to showcase the world leading R&D expertise and services within our membership, we are delighted to be supporting this Bio-Rad seminar on:

Learn How ddPCR is Enabling Rare Sequence Quantification and CRISPR Validation 

Take the undetectable and make it quantifiable - liquid biopsy, personalised medicine and other applications of absolute DNA quantification.

Bio-Rad seeks to constantly challenge the way our partners perform their basic research, drug discovery, diagnosis and production. At this Innovation Day we will cover the bright future of our market leading technology - Droplet Digital™ PCR.

Come along and discover: 

- How Droplet Digital PCR achieves absolute quantification with unrivalled precision
- How researchers are using ddPCR™ to make liquid biopsy and personalised medicine a reality 

- How this technology is improving on fluorescent in situ hybridization, real-time PCR and next generation sequencing 

- How Droplet Digital PCR is making waves in copy number variation, pathogen detection, environmental monitoring and more 

There will also be networking opportunities and time to talk with the experts. We all look forward to meeting you. 

10.30 - Registration and Coffee 

11.00 - The Holy Grail of Liquid Biopsy: How Personalised Medicine is Within Our Grasp 

Stephen Hague, Droplet Digital PCR Specialist, Bio-Rad Laboratories UK 

11.45 - Partnering Opportunities with Bio-Rad 

Tom Day, Life Sciences Group, Bio-Rad Laboratories UK 

12.00 - Lunch with Hands-On Session with the QX200™ Droplet Digital™ PCR System 

13.30 - Close


Registration is free with lunch and refreshments provided. 

Title: Learn how ddPCR is enabling rare sequence quantification and CRISPR validation
Start: 2015-06-03 10:30:00Z
End: 2015-06-03 13:30:00Z